Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3412)
All Articles published online
|
2013-05-28 (publication date) through 2024-09-20
Times Cited of This Article
Journal Information of This Article
Publication Name
世界华人消化杂志
ISSN
1009-3079
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | 高净, 江学良. 低剂量英夫利昔单抗不同给药次数治疗激素抵抗型溃疡性结肠炎. 世界华人消化杂志 2013; 21(15): 1453-1457 [DOI: 10.11569/wcjd.v21.i15.1453] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i15/1453.htm |
| Number | Citing Articles |
| 1 |
Rachel Archer, Paul Tappenden, Shijie Ren, Marrissa Martyn-St James, Rebecca Harvey, Hasan Basarir, John Stevens, Christopher Carroll, Anna Cantrell, Alan Lobo, Sami Hoque. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technology Assessment 2016; 20(39): 1 doi: 10.3310/hta20390
|